The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets

The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets

Pricing/manufacturer/marketer details for the Indian generic ledipasvir and sofosbuvir co-formulated tablets as on 10th January 2016.

Click here to see the full list.

/ News

Related Posts

20 YEARS AFTER THE TRIPS AGREEMENT, U.S. GOVERNMENT SCORES MASSIVE VICTORY FOR BIG PHARMA IN TPP DEAL
A two pager of what you need to know of Sofosbuvir
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Hepatitis C vaccine fails to prevent chronic infections
Progress report on access to hepatitis C treatment, WHO March 2018